Not available outside of the UK & Ireland.
Application
Milli-Mark Anti-CD79β-FITC Antibody, clone SN8 detects level of CD79β & has been published & validated for use in FC.
General description
CD79beta is restricted to the B-cell lineage, and is found in pro-B cells before Ig heavy-chain gene rearrangement but after CD79alpha expression. The antibody reacts with an epitope on the extracellular domain of CD79 (Yoshida, 1995). Anti-CD79beta, SN8, was included in the Fifth International Workshop and Conference on Human Leucocyte Differentiation Antigens, and studies by a number of laboratories confirmed its reactivity with CD79beta (Engel, 1995; Persin, 1995).
Legal Information
MILLI-MARK is a registered trademark of Merck KGaA, Darmstadt, Germany
Quality
Evaluated by flow cytometry using human lymphocytess
Specificity
Antibody recognizes Human CD79b antigen.
Target description
36 kDa
This product has met the following criteria to qualify for the following awards: